Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving blood clotting factor
Patent
1996-05-24
2000-09-05
Wityshyn, Michael G.
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving blood clotting factor
436 16, 424 9464, 424530, 424532, 514 2, 514802, C12Q 156, G01N 2100
Patent
active
061141356
ABSTRACT:
A multiple coagulation test system and method for determining an appropriate coagulation promoting substance for administration to a patient as a therapy for improving clotting function in said patient has at least three sample wells. One of the wells is for testing a baseline clotting indicator time of a patient's blood to serve as a control sample. Each of the other wells are for testing clotting indicator times of different coagulation promoting substances when mixed with the patient's blood. The coagulation promoting substances are agents or combination of agents capable of improving clotting function in the patient. An appropriate therapy for improving clotting function in the patient is determined by comparison of the baseline control clotting indicator time with the clotting indicator times of the coagulation promoting substances mixed with the patient's blood. Generally, the agent giving the lowest clotting indicator time is selected as an appropriate treatment for reducing hemorrhaging begun. Utilizing the inventive system eliminates the need to use a multiple agent approach, by identifying the most effective course of action in a rapid manner. The system and method are also easily adaptable to test coagulation inhibiting substances.
REFERENCES:
patent: 2616796 (1952-11-01), Schilling
patent: 3302452 (1967-02-01), Leslie
patent: 3695842 (1972-10-01), Mintz
patent: 3836333 (1974-09-01), Mintz
patent: 3918908 (1975-11-01), Moyer et al.
patent: 4000972 (1977-01-01), Braun et al.
patent: 4105411 (1978-08-01), Biver
patent: 4125327 (1978-11-01), Margolis
patent: 4135819 (1979-01-01), Schmid-Schonbein
patent: 4443408 (1984-04-01), Mintz
patent: 4497774 (1985-02-01), Scordato
patent: 4534939 (1985-08-01), Smith et al.
patent: 4599219 (1986-07-01), Cooper et al.
patent: 4640896 (1987-02-01), Farrell et al.
patent: 4659550 (1987-04-01), Schildknecht
patent: 4663127 (1987-05-01), Jackson et al.
patent: 4671939 (1987-06-01), Mintz
patent: 4752449 (1988-06-01), Jackson et al.
patent: 4782026 (1988-11-01), Baugh et al.
patent: 4865984 (1989-09-01), Nemerson et al.
patent: 4871677 (1989-10-01), Baugh et al.
patent: 4946775 (1990-08-01), Yin
patent: 5091304 (1992-02-01), La Duca et al.
patent: 5110727 (1992-05-01), Oberhardt
patent: 5184188 (1993-02-01), Bull et al.
patent: 5300779 (1994-04-01), Hillman et al.
patent: 5302348 (1994-04-01), Cusack et al.
patent: 5305745 (1994-04-01), Zacouto
patent: 5325295 (1994-06-01), Fratantoni et al.
patent: 5350676 (1994-09-01), Oberhardt et al.
patent: 5366869 (1994-11-01), Goldstein
patent: 5401663 (1995-03-01), Yonemura
patent: 5451509 (1995-09-01), Speck
Hemochron.RTM. Control Plasma Quality Control Test Kits, International Technidyne Corp., Dec. 1988.
Langdell, Robert D. et al., Effect of Antihemophilic Factor On One-Stage Clotting Tests (1953).
Proctor, Robert R., et al., "The Partial Thromboplastin Time With Kaolin", The Am. J. of Clinical Pathology, vol. 36, No. 3, pp. 212-219, Sep. 1961.
Goldstein, Sheldon, M.D., et al., "Heparin Anticoagulation For Cardiopulmonary Bypass", Futura Pub., 1991.
Austen, D.E., 6, et al., "A Laboratory Manual Of Blood Coagulation", Blackwell Scientific Pub. (1975).
Thrombo Screen.RTM. Universal Coagulation Reference Plasma, Pacific Hemostasis (Feb. 1990).
Bick, Rodger L., M.D. "Hemostatis Defects Associated With Cardiac Surgery . . . " Seminars in Thrombosis and Hemostasis, vol. II, No. 3 (1985).
Goodnough, Lawrence T., et al., "On the Need for Improved Transfusion Indicators in Cardiac Surgery", Ann Thorac Surg 1995; 60: 473-480.
Despotis, G.J. et al., "Prospective evaluation and clinical utility of on-site monitoring of coagulation in patients undergoing cardiac operation", The Journal of Thoracic and Cardiovascular Surgery, 1994 vol. 107, No. 1, pp. 271-279.
Gravlee, Glenn, et al., "Predictive Value of Blood Clotting Tests in Cardiac Surgical Patients", Ann Thorac Surg 1994:58:216-21.
Despotis, G.J. et al., "On-site Prothrombin Time, Activated Partial Thromboplastin Time, and Platelet Count", Anesthology, vol. 80, No. 2, pp. 338-351 (1994).
"Thrombocytopenia in Hypothermia: A Common But Poorly Recognized Complication," British Medical Journal, vol. 291, Jul. 6, 1985, p. 23
Cohen, IJ, "Cold Surgery in Early Infancy"Israeli Med. Sci. vol. 13, No. 4, Apr. 1977, pp. 405-409.
Despotis, G.J. et al., "Factors Associated With Excessive Post-Operative Blood Loss and Hemostatic Transfusion Requirements", Anesth Analg 1996; 82:13-21.
Anesth Analg 1989; 69:142-144, Letters to the Editor.
Johansson B.W. et al., "The Effect of Heparin and Aminocaproic Acid on the Coagulation in Hypothermic Dogs", Acta Physiol. Scand. 1964. 60 267-277.
Spiess, B.D. et al., "Thromboelastography As An Indicator Of Post-Cardio Pulmonary By-Pass Coagulopathies", Journal of Clinical Montoring, vol. 3, No. 1, Jan. 1987, pp. 25-30.
Jian-Sheng Wang "Thromboelastogram Fails to Predict Postoperative Hemorrhage In Cardiac Patients", Ann Thorac Surg 1992; 53: 435-9.
Essell, J.H. et al., "Comparison of Thromboelastography to Bleeding Time and Standard Coagulation Tests in Patients After a Cardio Pulmonary Bypass", Journal of Cardiothoracic and Vascular Anesthesia, vol. 7, No. 4, 1993, pp. 410-415.
Dorman, B.H. et al., "Identification of the Patients At Risk for Excessive Blood Loss During Coronary Artery Bypass Surgery", Anesth Analg 1993; 76: 694-700.
Tuman, K.J. et al., "Comprison of Viscoelastic Measures of Coagulation After a Cardiopulmonary By-pass", Anesth Analg 1989; 69: 69-75.
Jobes, D.R. et al., "Increased Accuracy in Precision of Heparin and Protamine Dosing" The Journal of Thracic and Cardiovascular Surgery vol. 110, No. 1, pp. 36-45 (Jul. 1995).
Despotis, G.J. et al., "The Impact of Heparin Concentration and Activated Clotting Time Monitoring on Blood Conservation", J. Thorac Cardiovascular Surg. 1995; 110: 46-54.
Burns, E.R. "Physiologic Response To Traumatic Bleeding", pp. 3-18, Blackwell Scientific, Boston, USA, 1987, in Clinical Management Of Bleeding And Thrombosis, Chapter 1.
Hathaway, William E. et al, "Disorders of Hemsotasis and Thrombosis", McGraw-Hill, Inc., pp. 338-241, 448-449 (1993).
Smiley, R.K. et al., "Studies On The Pronged Bleeding Time In Von Willebrand's Disease", Thrombosis Research, vol. 53, No. 5, pp. 417-426 (1989).
Chediak, Juan R., et al "Platelet Function and Immunologic Parameters in von Willebrand's Disease Following Cryoprecipitate and Factor VIII Concentrate Infusion", The American Journal of Medicine, vol. 62, Mar. 1977, pp. 369-375.
Hoffman, M. et al., "Fibrinogen content of low-volume cryoprecipitate", Transfusion, vol. 27, No. 4-1987, pp. 356-358.
Hattersley, Paul G., "The Treatment of Classical Hemphilia With Cryoprecipitates", JAMA, vol. 198, No. 3, Oct. 17, 1966, pp 153-57.
Janson, Paul A., et al. "Treatment Of The Bleeding Tendency In Uremia With Cryoprecipitate", The New England Journal Of Medicine, vol. 303, No. 23, Dec. 4, 1980, pp 1318-22.
Kerr Janet M.
Wityshyn Michael G.
LandOfFree
Multiple coagulation test system and method of using a multiple does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Multiple coagulation test system and method of using a multiple , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Multiple coagulation test system and method of using a multiple will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2211011